Soleno Therapeutics, Inc. (SLNO)
NASDAQ: SLNO · Real-Time Price · USD
51.37
-1.31 (-2.49%)
Dec 5, 2025, 4:00 PM EST - Market closed
Soleno Therapeutics Employees
Soleno Therapeutics had 92 employees as of December 31, 2024. The number of employees increased by 59 or 178.79% compared to the previous year.
Employees
92
Change (1Y)
59
Growth (1Y)
178.79%
Revenue / Employee
$1,072,554
Profits / Employee
-$852,717
Market Cap
2.76B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
SLNO News
- 1 day ago - Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc. (SLNO) Shareholders Who Have Incurred Losses - PRNewsWire
- 2 days ago - Soleno Turns First Profit on $66 Million in Revenue — Is This Why One Investor Just Made an $87 Million Bet? - The Motley Fool
- 2 days ago - Soleno Therapeutics Announces the Passing of Board Member William G. Harris - GlobeNewsWire
- 22 days ago - Soleno Therapeutics (SLNO) Faces Investor Scrutiny Amid Disappointing VYKAT XR Starts, Discontinuations; Shares Down 26% – Hagens Berman - GlobeNewsWire
- 24 days ago - Soleno Therapeutics, Inc. Investigated by the Portnoy Law Firm - GlobeNewsWire
- 25 days ago - Soleno Therapeutics Announces Entry Into $100 Million Accelerated Share Repurchase Agreement - GlobeNewsWire
- 4 weeks ago - Soleno Therapeutics (SLNO) Faces Investor Scrutiny Amid Disappointing VYKATÔ XR Starts, Discontinuations; Shares Down 26% -- Hagens Berman - PRNewsWire
- 4 weeks ago - Soleno Therapeutics, Inc. (SLNO) Q3 2025 Earnings Call Transcript - Seeking Alpha